Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study

Pharmacological evaluation of dotinurad, a selective urate reabsorption inhibitor

(2019) Tetsuya Taniguchi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study

(2017) Anne-Kathrin Tausche et al.   RHEUMATOLOGY

Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations

(2016) Hiroshi Miyata et al.   Frontiers in Pharmacology

Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension

(2014) Masanari Kuwabara et al.   HYPERTENSION RESEARCH

Hyperuricemia Is a Significant Risk Factor for the Onset of Chronic Kidney Disease

(2014) Akiko Toda et al.   NEPHRON CLINICAL PRACTICE

High Serum Uric Acid and Increased Risk of Type 2 Diabetes: A Systemic Review and Meta-Analysis of Prospective Cohort Studies

(2013) Qin Lv et al.   PLoS One

Decreased extra-renal urate excretion is a common cause of hyperuricemia

(2012) Kimiyoshi Ichida et al.   Nature Communications

Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition

(2011) Hisashi Yamanaka   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES